I share your optimism, but until cancer is proven in clinical trials (which I think it will), I am hesitant to incorporate such figures into my calculations as it becomes extremely large. If cancer is successful, then $30+ a share is very possible, but putting a time on share appreciation is difficult....and anything above $10 sounds crazy to me when we are currently at $.52 (that's a 20 bagger).